Tecarfarin (sodium)
Product Specifications
UNSPSC Description
Tecarfarin sodium (ATI-5923 sodium) is a novel orally active non-competitive vitamin K epoxide reductase (VKOR) antagonist, impairs the activation of the vitamin K-dependent clotting factors II, VII, IX and X[1].
Tecarfarin sodium has the antithrombotic activity[2].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/tecarfarin-sodium.html
Solubility
10 mM in DMSO
Smiles
O=C1C(CC2=CC=C(C(OC(C(F)(F)F)(C)C(F)(F)F)=O)C=C2)=C(O[Na])C3=C(O1)C=CC=C3
Molecular Weight
482.31
References & Citations
[1]Hobl EL, et al. Tecarfarin: A Novel Vitamin K Antagonist. Thromb Haemost. 2017 Nov;117(11):2009-2011.|[2]Bowersox SS, et al. Antithrombotic activity of the novel oral anticoagulant, Tecarfarin [Sodium 3-[4-((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in animal models. Thromb Res. 2010 Nov;126(5):e383-8.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-14854A/Tecarfarin-sodium-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14854A/
Clinical Information
Phase 3
CAS Number
1004551-83-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items